| Korean J Intern Med |
New synergistic efficacy of combination of romiplostim and steroid in refractory immune thrombocytopenia patients
|
| ANNALS OF HEMATOLOGY |
Improved prognostic stratification power of CIBMTR risk score with the addition of absolute lymphocyte and eosinophil counts at the onset of chronic GVHD
|
| ANNALS OF HEMATOLOGY |
Report on outcomes of hypomethylating therapy for analyzing prognostic value of Revised International Prognostic Scoring System for patients with lower-risk myelodysplastic syndromes
|
| Blood res |
Survey of experts on therapeutic policies and proposals for the optimal timing for allogeneic peripheral blood stem cell transplantation in transfusion-dependent patients with myelodysplastic syndrome-refractory anemia.
|
| CRITICAL REVIEWS IN ONCOLOGY HEMATOLOGY |
Survey of expert opinions and related recommendations regarding bridging therapy using hypomethylating agents followed by allogeneic transplantation for high-risk MDS
|
| ACTA HAEMATOLOGICA |
Outcomes of Allogeneic Hematopoietic Cell Transplantation in Acute Myeloid Leukemia Patients with Monosomal Karyotypes
|
| ANNALS OF TRANSPLANTATION |
Favorable Effects of Low-Dose Anti-Thymocyte Globulin in a Partially-Mismatched HLA Group in an Unrelated Allogeneic Stem Cell Transplantation Setting
|
| 대한내과학회지 |
만성골수성백혈병 한국 치료 가이드라인-대한혈액학회
|
| Blood Res. 2014 Sep;49(3):141-3 |
Is a cure for CML without allogeneic stem cell transplantation around the corner?
|
| TRANSFUSION |
Adoptable strategic approaches to improve outcomes of allogeneic peripheral blood stem cell transplantations from unrelated donors
|
| EXPERT REVIEW OF HEMATOLOGY |
When is the optimal timing for allogeneic transplantation in the case of MDS patients treated with hypomethylating agents?
|
| CANCER RESEARCH AND TREATMENT |
Clinical Outcome of Rituximab-Based Therapy (RCHOP) in Diffuse Large B-Cell Lymphoma Patients with Bone Marrow Involvement
|
| INTERNATIONAL JOURNAL OF HEMATOLOGY |
Two CML patients who subsequently developed features of essential thrombocythemia with JAK2-V617F mutation while in complete cytogenetic remission after treatment with imatinib mesylate
|
| ANNALS OF HEMATOLOGY |
Interim PET/CT-based prognostic model for the treatment of diffuse large B cell lymphoma in the post-rituximab era
|
| LEUKEMIA LYMPHOMA |
Absolute lymphocyte count at day+21 predicts survival in patients with early-stage diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, adriamycin, vincristine and prednisone
|
| Kor J Int Med |
Feasibility of non-TBI conditioning with busulfan and fludarabine for allogeneic stem cell transplantation in lymphoid malignancy
|
| ANNALS OF HEMATOLOGY |
Pilot study on combination of azacitidine and low-dose cytarabine for patients with refractory anemia with excess blast
|
| MEDICAL ONCOLOGY |
Patient counseling program to improve the compliance to imatinib in chronic myeloid leukemia patients
|
| 전남의대학술지 |
Prospective Randomization Trial of G-CSF-Primed Induction Regimen versus Standard Regimen in Patients with AML
|
| Acta haematol |
Comparable analysis of outcomes for allogeneic peripheral blood stem cell transplantation from matched related and matched unrelated donors in acute myeloid leukemia
|
| LEUKEMIA LYMPHOMA |
Trough plasma imatinib levels are correlated with optimal cytogenetic responses at 6 months after treatment with standard dose of imatinib in newly diagnosed chronic myeloid leukemia
|
| BONE MARROW TRANSPLANTATION |
Early onset of acute GVHD indicates worse outcome in terms of severity of chronic GVHD compared with late onset
|
| ANNALS OF HEMATOLOGY |
Comparative analysis of outcomes of allogeneic peripheral blood stem cell transplantation from related and unrelated donors
|
| ANNALS OF HEMATOLOGY |
Predictive value of pretreatment risk group and baseline LDH levels in MDS patients receiving azacitidine treatment
|
| ACTA HAEMATOLOGICA |
Pre-Emptive Treatment with Nilotinib after Second Allogeneic Transplantation in a Philadelphia Chromosome-Positive Acute Lymphoblastic Leukemia Patient with High Risk of Relapse
|
| CANCER CHEMOTHERAPY AND PHARMACOLOGY |
Lymphotoxin alfa and receptor-interacting protein kinase 1 gene polymorphisms may correlate with prognosis in patients with diffuse large B cell lymphoma treated with R-CHOP
|
| INTERNATIONAL JOURNAL OF HEMATOLOGY |
Chronic myeloid leukemia patient manifesting fatal hepatitis B virus reactivation during treatment with imatinib rescued by liver transplantation: case report and literature review
|
| JOURNAL OF CLINICAL APHERESIS |
Mobilization Effects of G-CSF, GM-CSF, and Darbepoetin-alpha for Allogeneic Peripheral Blood Stem Cell Transplantation
|
| TRANSPLANTATION |
Clinical Significance of Autoantibody Expression in Allogeneic Stem-Cell Recipients
|
| BONE MARROW TRANSPLANTATION |
Pilot study on the use of zoledronic acid to prevent bone loss in allo-SCT recipients
|
| 대한내과학회지 |
미만성 거대 B세포 림프종 환자 치료 후 절대림프구수 감소율의 예후적 의의
|
| AMERICAN JOURNAL OF HEMATOLOGY |
Impact of alemtuzumab as conditioning regimen component on transplantation outcomes in case of CMV-seropositive recipients and donors
|
| HAEMATOLOGICA-THE HEMATOLOGY JOURNAL |
The association between multidrug resistance-1 gene polymorphisms and outcomes of allogeneic HLA-identical stem cell transplantation
|
| 대한내과학회지 |
급성 골수성 백혈병의 효율적 치료를 위한 맞춤 치료 및 이식 전략
|
전체 34개 (페이지 1/1)
